Seeking Alpha

Sevion Therapeutics, Inc. (SVON)

From other sites
Visit Seeking Alpha's
SVON vs. ETF Alternatives
Company Description
The primary business of the Company is to utilize our patented and patent-pending technology related to antibody genes, antibody discovery technology, modified cow antibodies, and antibody drug candidates, and certain genes, primarily eukaryotic translation initiation Factor 5A, or Factor 5A,... More
Sector: Healthcare
Industry: Biotechnology
Country: United States